These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10520856)

  • 1. Anticardiolipin antibodies in patients with liver disease.
    Mangia A; Margaglione M; Cascavilla I; Gentile R; Cappucci G; Facciorusso D; Grandone E; Di Minno G; Rizzetto M; Andriulli A
    Am J Gastroenterol; 1999 Oct; 94(10):2983-7. PubMed ID: 10520856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome.
    Prieto J; Yuste JR; Beloqui O; Civeira MP; Riezu JI; Aguirre B; Sangro B
    Hepatology; 1996 Feb; 23(2):199-204. PubMed ID: 8591841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis.
    Elefsiniotis IS; Diamantis ID; Dourakis SP; Kafiri G; Pantazis K; Mavrogiannis C
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):721-6. PubMed ID: 12811301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group.
    Cacoub P; Musset L; Amoura Z; Guilani P; Chabre H; Lunel F; Poynard T; Opolon P; Piette JC
    J Rheumatol; 1997 Nov; 24(11):2139-44. PubMed ID: 9375873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke.
    Cojocaru IM; Cojocaru M; Iacob SA
    Rom J Intern Med; 2005; 43(1-2):89-95. PubMed ID: 16739869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum cardiolipin antibodies in patients with alcoholic cirrhosis].
    Gervais A; Czernichow B; Grunebaum L; Wiesel ML; Auperin A; Rivalland D; Gabanyi J; Goldstein L; Cazenave JP; Doffoël M
    Gastroenterol Clin Biol; 1996; 20(10):736-42. PubMed ID: 8991142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in chronic liver diseases.
    Panasiuk A
    Rocz Akad Med Bialymst; 2001; 46():106-12. PubMed ID: 11780553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies in chronic viral hepatitis. Do they have clinical consequences?
    Yuste JR; Prieto J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):717-9. PubMed ID: 12811300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
    Papatheodoridis GV; Chrysanthos N; Cholongitas E; Pavlou E; Apergis G; Tiniakos DG; Andrioti E; Theodossiades G; Archimandritis AJ
    J Hepatol; 2009 Nov; 51(5):931-8. PubMed ID: 19726097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
    Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
    Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease.
    Guptan RC; Thakur V; Malhotra V; Sarin SK
    J Assoc Physicians India; 2002 May; 50(5):651-5. PubMed ID: 12186118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.